Serum 25-hydroxyvitamin D levels and the risk of idiopathic central precocious puberty in girls

Detalhes bibliográficos
Autor(a) principal: Gan, Dong-Mei
Data de Publicação: 2023
Outros Autores: Fang, Jie, Zhang, Ping-Ping, Zhao, Yu-Dan, Xu, Ya-Nan
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/214049
Resumo: Introduction: Prior studies have found inconsistent results regarding the relationship between vitamin D status and Idiopathic Central Precocious Puberty (ICPP). Objective: To assess the role of serum 25-hydroxyvitamin D (25 [OH]D) levels in ICPP development. Method: The authors retrospectively collected data from 221 girls with ICPP and 144 healthy girls between January 2017 and December 2019. The participants’ serum 25(OH)D levels were measured using an automatic chemiluminescence method, and the association between serum 25(OH)D levels and the risk of ICPP was assessed using multivariate logistic regression analysis. Odds Ratios (OR) with 95% Confidence Intervals (95% CI) were calculated as effect estimates. Results: Serum 25(OH)D levels in the ICPP group were significantly lower than those in healthy controls (p < 0.001). Multivariate analysis indicated that girls with insufficient vitamin D levels (OR = 0.201; 95% CI 0.094–0.428; p < 0.001) and sufficient vitamin D levels (OR = 0.141; 95% CI 0.053–0.375; p < 0.001) both had a lower risk of ICPP than girls with vitamin D deficiency. Moreover, the authors found that the height (p = 0.014), weight (p = 0.014), breast stage (p = 0.010), mother's height (p < 0.001), and luteinizing hormone/follicle-stimulating hormone ratio (p = 0.010) in girls with ICPP could be associated with levels of vitamin D. Conclusion: This study found that a low serum 25(OH)D level is an independent risk factor for ICPP, and several characteristics of girls with ICPP could be affected by their vitamin D status.:
id USP-19_bcddb0c69156575692a9541da2a020af
oai_identifier_str oai:revistas.usp.br:article/214049
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Serum 25-hydroxyvitamin D levels and the risk of idiopathic central precocious puberty in girlsIdiopathic central precocious pubertySerum 25-hydroxyvitamin DGirlsRisk factorsIntroduction: Prior studies have found inconsistent results regarding the relationship between vitamin D status and Idiopathic Central Precocious Puberty (ICPP). Objective: To assess the role of serum 25-hydroxyvitamin D (25 [OH]D) levels in ICPP development. Method: The authors retrospectively collected data from 221 girls with ICPP and 144 healthy girls between January 2017 and December 2019. The participants’ serum 25(OH)D levels were measured using an automatic chemiluminescence method, and the association between serum 25(OH)D levels and the risk of ICPP was assessed using multivariate logistic regression analysis. Odds Ratios (OR) with 95% Confidence Intervals (95% CI) were calculated as effect estimates. Results: Serum 25(OH)D levels in the ICPP group were significantly lower than those in healthy controls (p < 0.001). Multivariate analysis indicated that girls with insufficient vitamin D levels (OR = 0.201; 95% CI 0.094–0.428; p < 0.001) and sufficient vitamin D levels (OR = 0.141; 95% CI 0.053–0.375; p < 0.001) both had a lower risk of ICPP than girls with vitamin D deficiency. Moreover, the authors found that the height (p = 0.014), weight (p = 0.014), breast stage (p = 0.010), mother's height (p < 0.001), and luteinizing hormone/follicle-stimulating hormone ratio (p = 0.010) in girls with ICPP could be associated with levels of vitamin D. Conclusion: This study found that a low serum 25(OH)D level is an independent risk factor for ICPP, and several characteristics of girls with ICPP could be affected by their vitamin D status.:Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2023-07-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/21404910.1016/j.clinsp.2023.100244Clinics; Vol. 78 (2023); 100244Clinics; v. 78 (2023); 100244Clinics; Vol. 78 (2023); 1002441980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/214049/196280Copyright (c) 2023 Clinicsinfo:eu-repo/semantics/openAccessGan, Dong-MeiFang, JieZhang, Ping-PingZhao, Yu-DanXu, Ya-Nan2023-07-06T13:05:40Zoai:revistas.usp.br:article/214049Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2023-07-06T13:05:40Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Serum 25-hydroxyvitamin D levels and the risk of idiopathic central precocious puberty in girls
title Serum 25-hydroxyvitamin D levels and the risk of idiopathic central precocious puberty in girls
spellingShingle Serum 25-hydroxyvitamin D levels and the risk of idiopathic central precocious puberty in girls
Gan, Dong-Mei
Idiopathic central precocious puberty
Serum 25-hydroxyvitamin D
Girls
Risk factors
title_short Serum 25-hydroxyvitamin D levels and the risk of idiopathic central precocious puberty in girls
title_full Serum 25-hydroxyvitamin D levels and the risk of idiopathic central precocious puberty in girls
title_fullStr Serum 25-hydroxyvitamin D levels and the risk of idiopathic central precocious puberty in girls
title_full_unstemmed Serum 25-hydroxyvitamin D levels and the risk of idiopathic central precocious puberty in girls
title_sort Serum 25-hydroxyvitamin D levels and the risk of idiopathic central precocious puberty in girls
author Gan, Dong-Mei
author_facet Gan, Dong-Mei
Fang, Jie
Zhang, Ping-Ping
Zhao, Yu-Dan
Xu, Ya-Nan
author_role author
author2 Fang, Jie
Zhang, Ping-Ping
Zhao, Yu-Dan
Xu, Ya-Nan
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Gan, Dong-Mei
Fang, Jie
Zhang, Ping-Ping
Zhao, Yu-Dan
Xu, Ya-Nan
dc.subject.por.fl_str_mv Idiopathic central precocious puberty
Serum 25-hydroxyvitamin D
Girls
Risk factors
topic Idiopathic central precocious puberty
Serum 25-hydroxyvitamin D
Girls
Risk factors
description Introduction: Prior studies have found inconsistent results regarding the relationship between vitamin D status and Idiopathic Central Precocious Puberty (ICPP). Objective: To assess the role of serum 25-hydroxyvitamin D (25 [OH]D) levels in ICPP development. Method: The authors retrospectively collected data from 221 girls with ICPP and 144 healthy girls between January 2017 and December 2019. The participants’ serum 25(OH)D levels were measured using an automatic chemiluminescence method, and the association between serum 25(OH)D levels and the risk of ICPP was assessed using multivariate logistic regression analysis. Odds Ratios (OR) with 95% Confidence Intervals (95% CI) were calculated as effect estimates. Results: Serum 25(OH)D levels in the ICPP group were significantly lower than those in healthy controls (p < 0.001). Multivariate analysis indicated that girls with insufficient vitamin D levels (OR = 0.201; 95% CI 0.094–0.428; p < 0.001) and sufficient vitamin D levels (OR = 0.141; 95% CI 0.053–0.375; p < 0.001) both had a lower risk of ICPP than girls with vitamin D deficiency. Moreover, the authors found that the height (p = 0.014), weight (p = 0.014), breast stage (p = 0.010), mother's height (p < 0.001), and luteinizing hormone/follicle-stimulating hormone ratio (p = 0.010) in girls with ICPP could be associated with levels of vitamin D. Conclusion: This study found that a low serum 25(OH)D level is an independent risk factor for ICPP, and several characteristics of girls with ICPP could be affected by their vitamin D status.:
publishDate 2023
dc.date.none.fl_str_mv 2023-07-05
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/214049
10.1016/j.clinsp.2023.100244
url https://www.revistas.usp.br/clinics/article/view/214049
identifier_str_mv 10.1016/j.clinsp.2023.100244
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/214049/196280
dc.rights.driver.fl_str_mv Copyright (c) 2023 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 78 (2023); 100244
Clinics; v. 78 (2023); 100244
Clinics; Vol. 78 (2023); 100244
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222767422898176